← Back to Clinical Trials
Recruiting NCT06775106

NCT06775106 Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06775106
Status Recruiting
Phase
Sponsor Oregon Health and Science University
Condition Pulmonary Disease
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2024-11-30
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 120 Years
Study Type OBSERVATIONAL
Interventions
There is no intervention in this observational study

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2024-11-30 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to use mass spectrometry techniques to analyze exhaled patient breath in non-COVID ICU-admitted patients requiring ventilation for a rapid and accurate early detection of pulmonary diseases and inflammatory markers.

Eligibility Criteria

Inclusion Criteria: * Non-COVID-19 adult consented patients (\>18yo) on ventilatory support in the ICU at OHSU Exclusion Criteria: * Patients with "severe respiratory distress" as defined by arterial pO2 of \<60 mmHg on maximal FiO2 \& optimal ventilator settings * Patient with severe hemodynamic instability as defined by (a) receiving IV infusion of 2 or more pressors or inotropic medications (Levophed, vasopressin, phenylephrine, or epinephrine) \& (b) MAP of \<60 mmHg or SB \<80 mmHg

Contact & Investigator

Central Contact

Laura H Nguyen, B.S.

✉ nguyelau@ohsu.edu

📞 503-418-4733

Frequently Asked Questions

Who can join the NCT06775106 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 120 Years, studying Pulmonary Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06775106 currently recruiting?

Yes, NCT06775106 is actively recruiting participants. Contact the research team at nguyelau@ohsu.edu for enrollment information.

Where is the NCT06775106 trial being conducted?

This trial is being conducted at Portland, United States.

Who is sponsoring the NCT06775106 clinical trial?

NCT06775106 is sponsored by Oregon Health and Science University. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology